Prelude Therapeutics Inc - PRLD

Sector: Healthcare · Industry: Pharmaceutical Preparations

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q1 2026 · Q4 2025

Value (USD)

Total reported value ($000)

$110.1M

QoQ value delta ($000)

+$27.43M (+33.2%)

Implied price effect (QoQ)

+17.02%

Total shares

32,444,702

QoQ shares delta

+3,939,887 (+13.82%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q1 2026 data: 55 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
ORBIMED ADVISORS LLC	37,309	10,909,256	0.74%
BAKER BROS. ADVISORS LP	34,623	10,123,824	0.2%
Kynam Capital Management, LP	5,446	1,592,551	0.34%
VANGUARD CAPITAL MANAGEMENT LLC	4,207	1,230,406	0.0%
VANGUARD GROUP INC	4,100	1,413,986	0.0%
EcoR1 Capital, LLC	3,238	947,049	0.14%
TWO SIGMA INVESTMENTS, LP	3,158	923,626	0.0%
SPHERA FUNDS MANAGEMENT LTD.	1,909	558,339	0.3%
ACADIAN ASSET MANAGEMENT LLC	1,747	511,519	0.0%
MILLENNIUM MANAGEMENT LLC	1,308	382,737	0.0%
MARSHALL WACE, LLP	1,227	358,906	0.0%
MORGAN STANLEY	1,101	322,161	0.0%
BlackRock, Inc.	1,100	321,886	0.0%
GEODE CAPITAL MANAGEMENT, LLC	1,034	302,458	0.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP	987	288,788	0.0%
RENAISSANCE TECHNOLOGIES LLC	941	275,200	0.0%
GOLDMAN SACHS GROUP INC	808	236,469	0.0%
TWO SIGMA ADVISERS, LP	688	237,300	0.0%
JANE STREET GROUP, LLC	659	192,963	0.0%
VANGUARD FIDUCIARY TRUST CO	538	157,380	0.0%
ADAR1 Capital Management, LLC	522	152,825	0.03%
STATE STREET CORP	472	138,231	0.0%
CITADEL ADVISORS LLC	425	124,378	0.0%
Connor, Clark & Lunn Investment Management Ltd.	373	109,085	0.0%
UBS Group AG	220	64,505	0.0%